Skip to main content
Top
Published in: Clinical & Experimental Metastasis 5/2016

01-06-2016 | Research Paper

Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines

Authors: YeonHee Moon, Donghwi Kim, HongMoon Sohn, Wonbong Lim

Published in: Clinical & Experimental Metastasis | Issue 5/2016

Login to get access

Abstract

Oral squamous cell carcinoma (OSCC) is one of the most common cancers in the world. In OSCC, CD133 promotes tumor invasion and metastasis by inducing the epithelial-to-mesenchymal transition (EMT). A small subset of cancer cells known as cancer stem cells (CSCs) are thought to give rise to differentiated tumor cells and to predict tumor recurrence and metastases, i.e., CSCs may be metastatic precursors. In this study, we show that ectopic overexpression of CD133 in OSCC cell lines KB, YD9, and YD10B cells significantly promotes the EMT and acquisition of stemness properties. CSC properties were analyzed by colony-formation assay and measurement of OCT4, SOX2, and NANOG expression, and the EMT was monitored by cell migration, a cell invasion assay, and analysis of E-cadherin, N-cadherin, and vimentin expression. CD133 overexpression led to formation of irregular spheroid colonies consistent with a stem cell phenotype and increased the expression of OCT4, SOX2, NANOG, N-cadherin, and vimentin. Taken together, these findings show that elevated levels of CD133 lead to OSCC invasiveness and metastasis, associated with the upregulation of EMT and stemness markers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359(11):1143–1154CrossRefPubMed Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359(11):1143–1154CrossRefPubMed
3.
4.
go back to reference DiTroia JF (1972) Nodal metastases and prognosis in carcinoma of the oral cavity. Otolaryngol Clin N Am 5(2):333–342 DiTroia JF (1972) Nodal metastases and prognosis in carcinoma of the oral cavity. Otolaryngol Clin N Am 5(2):333–342
5.
go back to reference Roepman P et al (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37(2):182–186CrossRefPubMed Roepman P et al (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37(2):182–186CrossRefPubMed
6.
go back to reference Noguti J et al (2012) Metastasis from oral cancer: an overview. Cancer Gen Proteomics 9(5):329–335 Noguti J et al (2012) Metastasis from oral cancer: an overview. Cancer Gen Proteomics 9(5):329–335
7.
go back to reference Hirshberg A et al (2008) Metastatic tumours to the oral cavity—pathogenesis and analysis of 673 cases. Oral Oncol 44(8):743–752CrossRefPubMed Hirshberg A et al (2008) Metastatic tumours to the oral cavity—pathogenesis and analysis of 673 cases. Oral Oncol 44(8):743–752CrossRefPubMed
8.
go back to reference Ho CM et al (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14(5):359–363CrossRefPubMed Ho CM et al (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14(5):359–363CrossRefPubMed
9.
go back to reference Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755–768CrossRefPubMed Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755–768CrossRefPubMed
11.
go back to reference Liu S et al (2015) G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Oncotarget 6(9):6887–6901CrossRefPubMedPubMedCentral Liu S et al (2015) G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Oncotarget 6(9):6887–6901CrossRefPubMedPubMedCentral
12.
go back to reference Angelastro JM, Lame MW (2010) Overexpression of CD133 promotes drug resistance in C6 glioma cells. Mol Cancer Res MCR 8(8):1105–1115CrossRefPubMed Angelastro JM, Lame MW (2010) Overexpression of CD133 promotes drug resistance in C6 glioma cells. Mol Cancer Res MCR 8(8):1105–1115CrossRefPubMed
13.
go back to reference Zhang Q et al (2010) A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 289(2):151–160CrossRefPubMed Zhang Q et al (2010) A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 289(2):151–160CrossRefPubMed
14.
go back to reference Corbeil D et al (2000) The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275(8):5512–5520CrossRefPubMed Corbeil D et al (2000) The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275(8):5512–5520CrossRefPubMed
15.
go back to reference Hilbe W et al (2004) CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57(9):965–969CrossRefPubMedPubMedCentral Hilbe W et al (2004) CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57(9):965–969CrossRefPubMedPubMedCentral
17.
go back to reference Chu P et al (2009) Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer 124(6):1312–1321CrossRefPubMed Chu P et al (2009) Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer 124(6):1312–1321CrossRefPubMed
18.
go back to reference Chiou SH et al (2008) Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14(13):4085–4095CrossRefPubMed Chiou SH et al (2008) Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14(13):4085–4095CrossRefPubMed
19.
go back to reference Carvalho AL et al (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114(5):806–816CrossRefPubMed Carvalho AL et al (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114(5):806–816CrossRefPubMed
20.
go back to reference Yang CC et al (2013) Membrane type 1 matrix metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. BMC Cancer 13:171CrossRefPubMedPubMedCentral Yang CC et al (2013) Membrane type 1 matrix metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. BMC Cancer 13:171CrossRefPubMedPubMedCentral
21.
22.
go back to reference Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplas 15(2):117–134CrossRef Micalizzi DS, Farabaugh SM, Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplas 15(2):117–134CrossRef
23.
go back to reference Xu MH et al (2014) EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells. PloS One 9(2):e87893CrossRefPubMedPubMedCentral Xu MH et al (2014) EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells. PloS One 9(2):e87893CrossRefPubMedPubMedCentral
25.
go back to reference Kang HJ, Jang YJ (2012) Selective apoptotic effect of Zelkova serrata twig extract on mouth epidermoid carcinoma through p53 activation. Int J Or Sci 4(2):78–84CrossRefPubMedCentral Kang HJ, Jang YJ (2012) Selective apoptotic effect of Zelkova serrata twig extract on mouth epidermoid carcinoma through p53 activation. Int J Or Sci 4(2):78–84CrossRefPubMedCentral
26.
go back to reference Lee EJ et al (2005) Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 37(5):379–390CrossRefPubMed Lee EJ et al (2005) Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 37(5):379–390CrossRefPubMed
27.
go back to reference Pang LY et al (2012) Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition. Vet J 193(1):46–52CrossRefPubMed Pang LY et al (2012) Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition. Vet J 193(1):46–52CrossRefPubMed
28.
go back to reference Zhou BB et al (2009) Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8(10):806–823CrossRefPubMed Zhou BB et al (2009) Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8(10):806–823CrossRefPubMed
30.
go back to reference Iannolo G et al (2008) Apoptosis in normal and cancer stem cells. Crit Rev Oncol Hematol 66(1):42–51CrossRefPubMed Iannolo G et al (2008) Apoptosis in normal and cancer stem cells. Crit Rev Oncol Hematol 66(1):42–51CrossRefPubMed
31.
32.
go back to reference Bourguignon LY et al (2012) Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem 287(39):32800–32824CrossRefPubMedPubMedCentral Bourguignon LY et al (2012) Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem 287(39):32800–32824CrossRefPubMedPubMedCentral
33.
go back to reference Gangopadhyay S et al (2013) Breast cancer stem cells: a novel therapeutic target. Clin Breast Cancer 13(1):7–15CrossRefPubMed Gangopadhyay S et al (2013) Breast cancer stem cells: a novel therapeutic target. Clin Breast Cancer 13(1):7–15CrossRefPubMed
Metadata
Title
Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines
Authors
YeonHee Moon
Donghwi Kim
HongMoon Sohn
Wonbong Lim
Publication date
01-06-2016
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 5/2016
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-016-9793-y

Other articles of this Issue 5/2016

Clinical & Experimental Metastasis 5/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine